The role of new anesthetic agents

Pharmacology and Therapeutics

Volumn 84, Issue 3, 1999, Pages 233-248

  O'Keeffe, N J ^a   Healy, T E J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anesthetics:local; Anesthetics:volatile; Desflurane; Ropivacaine; Sevoflurane

Indexed keywords

ANESTHETIC AGENT; BUPIVACAINE; DESFLURANE; HALOTHANE; ISOFLURANE; MUSCLE RELAXANT AGENT; NICARDIPINE; NITROUS OXIDE; OPIATE; ROPIVACAINE; SEVOFLURANE; SODIUM CARBONATE;

ANESTHESIA; HUMAN; LIVER TOXICITY; MALIGNANT HYPERTHERMIA; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032763710     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00034-0     Document Type: Review

References (164)

1. Abboud T.K., Swart F., Zhu J., Donovan M.M., Peres da Silva E., Yakal K. Desflurane analgesia for vaginal delivery. Acta Anaesthesiol Scand. 39:1995;259-261. a.
2. Abboud T.K., Zhu J., Richardson M., Peres da Silva E., Donovan M. Desflurane. a new volatile anaesthetic for cesarean section. Maternal and neonatal effects Acta Anaesthesiol Scand. 39:1995;723-726. b.
3. Allen G.C., Brubaker C.L. Human malignant hyperthermia associated with desflurane anesthesia. Anesth Analg. 86:1998;1328-1331.
4. Aono J., Ueda W., Mamiya K., Takimoto E., Manabe M. Greater incidence of delirium during recovery from sevoflurane anesthesia in preschool boys. Anesthesiology. 87:1997;1298-1300.
5. Bader A.M., Datta S., Flanagan H., Covino B.G. Comparison of bupivacaine and ropivacaine induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg. 68:1989;724-727.
6. Baxter P.J., Kharasch E.D. Rehydration of desiccated Baralyme prevents carbon monoxide formation from desflurane in an anesthesia machine. Anesthesiology. 86(5):1997;1061-1065.
7. Bernard J.B., Doursout M.F., Wouters P., Hartley C.J., Merin R.G., Chelly J.E. Effects of sevoflurane and isoflurane on hepatic circulation in the chronically instrumented dog. Anesthesiology. 77:1992;541-545.
8. Bito H., Ikeuchi Y., Ikeda K. Effects of the water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia. Anesthesiology. 88:1998;66-71.
9. Boban M., Stowe D.F., Buljabasic N., Kampine J.P., Bosnjak Z.J. Direct comparative effects of isoflurane and desflurane in isolated guinea pig hearts. Anesthesiology. 76:1992;775-780.
10. Bunting H.E., Kelly M.C., Milligan K.R. Effects of nebulized lignocaine on airway irritation and hemodynamic changes during induction of anesthesia with desflurane. Br J Anaesth. 75:1995;631-633.
11. Cahalan M.K., Weiskopf R.B., Eger E.I. II, Yasuda N., Pompilu I., Rampil I.J., Lockhart S.H., Freire B., Peterson N.A. Hemodynamic effects of desflurane/nitrous oxide anesthesia in volunteers. Anesth Analg. 73:1991;143-156.
12. Caldwell J.E., Laster M.J., Magorian T., Heier T., Yasuda N., Lynam D.P., Eger E.I. II, Weiskopf R.B. The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans. Anesthesiology. 74:1991;412-418.
13. Campbell C., Andreen M., Battito M.F., Camporesi E.M., Goldberg M.E., Grounds R.M., Hobbhahn J., Lumb P., Murray J.M., Solanki D.R., Heard S.O., Coriat P. A phase III, multi-center, open-label, randomized, comparative study evaluating the effect of sevoflurane versus isoflurane on the maintenance of anesthesia in adult ASA class I, II, and III inpatients. J Clin Anesth. 8:1996;557-563.
14. Cederholm I., Akerman B., Evers H. Local analgesic and vascular effects of intradermal ropivacaine and bupivacaine in various concentrations with and without addition of adrenaline in man. Acta Anaesthesiol Scand. 38:1994;322-327.
15. Cousins M.J., Mazze R.I. Methoxyflurane toxicity. a study of dose response in man JAMA. 225:1973;1611-1616.
16. Crandell W.B., Pappas S.G., MacDonald A. Nephrotoxicity associated with methoxyflurane anesthesia. Anesthesiology. 27:1966;591-607.
17. Dale O. Drug interactions in anesthesia. focus on desflurane and sevoflurane Baillieres Clin Anaesthesiol. 9:1995;105-117.
18. Datta S., Camann W., Bader A., Vanderburgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology. 82:1995;1346-1352.
19. Dexter F., Tinker J.H. Comparisons between desflurane and isoflurane or propofol on time to following commands and time to discharge. A meta-analysis. Anesthesiology. 83:1995;77-82.
20. Doi M., Ikeda K. Respiratory effects of sevoflurane. Anesth Analg. 66:1987;241-244.
21. Doi M., Ikeda K. Airway irritation produced by volatile anesthetics during brief inhalation. comparison of halothane, enflurane, isoflurane and sevoflurane Can J Anaesth. 40:1993;122-126.
22. Doi M., Takahashi T., Ikeda K. Respiratory effects of sevoflurane used in combination with nitrous oxide and surgical stimulation. J Clin Anesth. 6:1994;1-4.
23. Ebert T.J., Muzi M., Lopatka C.W. Neuro-circulatory responses to sevoflurane in humans. A comparison to desflurane. Anesthesiology. 83:1995;88-95.
24. Ebert T.J., Kharasch E.D., Rooke G.A., Shroff A., Muzi M. Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group. Anesth Analg. 85:1997;993-999.
25. Ebert T.J., Messana L.D., Uhrich T.D., Staacke T.S. Absence of renal and hepatic toxicity after 4 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesth Analg. 86:1998;662-667.
26. Eger E.I. II Partition coefficients of I-653 in human blood, saline, and olive oil. Anesth Analg. 66:1987;971-973.
27. Eger E.I. II New inhaled anesthetics. Anesth Analg. 80:1994;906-922.
28. Eger E.I. II, Saidman L.J., Brandstater B. Minimum alveolar anaesthetic concentration. a standard of anesthetic potency Anesthesiology. 26:1965;756-763.
29. Eger E.I. II, Gong D., Koblin D.D., Bowland T., Ionescu P., Laster M.J., Weiskopf R.B. Dose related markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg. 85:1997;1154-1163. a.
30. Eger E.I. II, Koblin D.D., Bowland T., Ionescu P., Laster M.J., Fang Z., Gong D., Sonner J., Weiskopf R.B. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg. 84:1997;160-168. b.
31. El Mikatti N., Healy T.E.J. Hepatic injury associated with halogenated anaesthetics. cross sensitization and its clinical implications Eur J Anaesth. 14:1997;7-14.
32. Emanuelsson B.M.K., Persson J., Aim C., Heller A., Gustafsson L.L. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology. 87:1997;1309-1317.
33. Erichsen C.J., Sjovall J., Kehlet H., Hedlund C., Arvidsson T. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology. 84:1996;834-842.
34. Eriksson H., Korttila K. Recovery profile after desflurane with or without ondansetron compared with propofol in patients undergoing outpatient gynecological laparoscopy. Anesth Analg. 82:1996;533-538.
35. Fang Z.X., Eger E.I. II, Laster M., Chortkoff B., Kandel L., Ionescu P. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg. 80:1995;1187-1193.
36. Feldman H.S., Arthur G.R., Covino B.G. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in the conscious dog. Anesth Analg. 69:1989;794-801.
37. Finucane B.T., Sandler A.N., McKenna J., Reid D., Milner A.L., Friedlander M., Muzyka D., O'Callaghan-Enright S., Chan V. A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy. Can J Anaesth. 43:1996;442-449.
38. Fisher D.M., Zwass M.S. MAC of desflurane in 60% nitrous oxide in infants and children. Anesthesiology. 79:1992;354-356.
39. Frink E.J. Jr., Ghantous H., Malan T.P. Plasma inorganic fluoride with sevoflurane anesthesia. correlation with indices of renal and hepatic function Anesth Analg. 74:1992;231-235. a.
40. Frink E.J. Jr., Malan T.P., Atlas M., Dominguez L.M., DiNardo J.A., Brown B.R. Jr. Clinical comparison of sevoflurane and isoflurane in healthy patients. Anesth Analg. 74:1992;241-245. b.
41. Fu E.S., Scharf J.E., Mangar D., Miller W.D. Malignant hyperthermia involving the administration of desflurane. Can J Anaesth. 43:1996;687-690.
42. Gherardini G., Samuelson U., Jernbeck J., Aberg B., Sjostrand N. Comparison of effects of ropivacaine and lidocaine on isolated rings of human arteries. Acta Anesthesiol Scand. 39:1995;765-768.
43. Ghouri A.F., White P.F. Comparative effects of desflurane and isoflurane on neuromuscular function. Anesth Analg. 72:1991;S88.
44. Gold M.I., Abello D., Herrington C. Minimum alveolar concentration of desflurane in patients older than 65 yr. Anesthesiology. 79:1993;710-714.
45. Halldin M.M., Bredberg E., Angelin B., Arvidsson T., Askemark Y., Elofsson S. Metabolism and excretion of ropivacaine in humans. Drug Metab Dispos. 24:1996;962-968.
46. Hartman J.C., Kelly R.E., Embree P.B., Sharp J.G., Artusio J.F. Jr. Vital capacity rapid inhalation induction (VCRII) with desflurane. Anesthesiology. 73:1990;A20.
47. Hartman J.C., Pagel P.S., Kampine J.P., Warltier D.C. Influence of desflurane on regional blood flow in a chronically instrumented canine model of multi vessel coronary artery obstruction. Anesth Analg. 72:1991;289-299.
48. Hatakeyama N., Ito Y., Momose Y. Effects of sevoflurane, isoflurane and halothane on mechanical and electro-physicological properties of canine myocardium. Anesth Analg. 76:1993;1327-1332.
49. Helman J.D., Leung J.M., Bellows W.H., Pineda N., Roach G.W., Reeves J.D., Howse J., McEnany M.T., Mangano D.T. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. Anesthesiology. 77:1992;47-62.
50. Hickey R., Hoffman J., Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine for brachial plexus block. Anesthesiology. 74:1991;639-642.
51. Holaday D.A., Smith F.R. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology. 54:1981;100-106.
52. Holaday D.A., Fiserova-Bergerova V., Latto I.P., Zumbiel M.A. Resistance of isoflurane to biotransformation in man. Anesthesiology. 84:1975;1332-1340.
53. Iida H., Watanabe Y., Dohi S., Ishiyama T. Direct effects of ropivacaine and bupivacaine on spinal pial vessels in canine. Assessment with closed spinal window technique. Anesthesiology. 87:1997;75-81.
54. Inomata S., Watanabe S., Taguchi M., Okada M. End-tidal sevoflurane concentration for tracheal intubation and minimum alveolar concentration in pediatric patients. Anesthesiology. 80:1994;93-96.
55. Irestedt L., Emanuelsson B.M., Ekbolm A., Olofsson C., Reventlid H. Ropivacaine 7.5mg/ml for elective cesarean section. A clinical and pharmacokinetic comparison of 150mg and 187.5mg. Acta Anaesthesiol Scand. 41:1997;1149-1156.
56. Ishibe Y., Gui X., Uno H., Shiokawa Y., Umeda T., Suekane K. Effect of sevoflurane on hypoxic pulmonary vasoconstriction in the perfused rabbit lung. Anesthesiology. 79:1993;1348-1353.
57. Izawa H., Takeda J., Fukushima K. The interaction between vecuronium and sevoflurane and its reversibility by neostigmine in man. Anesthesiology. 77:1992;A960.
58. Jellish W.S., Lien C.A., Fontenot H.J., Hall R. The comparative effects of sevoflurane versus propofol in the induction and maintenance of anesthesia in adult patients. Anesth Analg. 82:1996;479-485.
59. Jiaxiang N., Sato N., Fojii K., Yuge O. Urinary excretion of hexafluoroisopropanol glucuronide and fluoride in the urine in patients after sevoflurane anesthesia. J Pharm Pharmacol. 45:1993;67-69.
60. Johannesson G.P., Floren M., Lindahl S.G. Sevoflurane for ENT-surgery in children. A comparison with halothane. Acta Anaesthesiol Scand. 39:1995;546-550.
61. Johnston R.R., Eger E.I. II, Wilson C. A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man. Anesth Analg. 55:1976;709-712.
62. Jones R.M., Cashman J.N., Eger E.I. II, Damask M.C., Johnson B.H. Kinetics and potency of desflurane (I-653) in volunteers. Anesth Analg. 70:1990;3-7. a.
63. Jones R.M., Cashman J.N., Mant T.G.K. Clinical impressions and cardiorespiratory effects of a new fluorinated inhalation anaesthetic, desflurane (I-653) in volunteers. Br J Anaesth. 64:1990;11-15. b.
64. Kameyama Y. Effect of isoflurane and sevoflurane on evoked potentials and EEG. Masui. 43:1994;657-664.
65. Katoh T., Ikeda K. The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology. 66:1987;301-303.
66. Katoh T., Ikeda K. A comparison of sevoflurane with halothane, enflurane and isoflurane on bronchoconstriction caused by histamine. Can J Anaesth. 41:1994;1214-1219.
67. Katoh T., Ikeda K. The effect of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology. 88:1998;18-24.
68. Katz J.A., Bridenbaugh P.O., Knarr D.C., Helton S.H., Denson D.D. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans. Anesth Analg. 70:1990;16-21.
69. Kenna J.G., Jones M.J. The organ toxicity of inhaled anesthetics. Anesth Analg. 81:1995;S51-S66.
70. Kenna J.G., Satoh H., Christ D.D., Pohl L.R. Metabolic basis for drug hypersensitivity. antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoracetyl group derive J Pharmacol Exp Ther. 245:1988;1103-1109.
71. Kersten J.R., Brayer A.P., Pagel P.S., Tessmer J.P., Warltier D.C. Perfusion of ischemic myocardium during anesthesia with sevoflurane. Anesthesiology. 81:1994;995-1004.
72. Kharasch E.D., Thummel K.E. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane. Anesthesiology. 79:1993;795-807.
73. Kharasch E.D., Hankins D.C., Thummel K.E. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane toxicity. Anesthesiology. 82:1995;689-699. a.
74. Kharasch E.D., Karol M.D., Lanni C., Sawchuk R. Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology. 82:1995;1369-1378. b.
75. Kimura T., Watanabe S., Asakura N., Inomata S., Okada M., Taguchi M. Determination of end tidal sevoflurane concentration for tracheal intubation and minimum alveolar concentration in adults. Anesth Analg. 79:1994;378-381.
76. Kitaguchi K., Ohsumi H., Kuro M., Nakajima T., Hatashi Y. Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiology. 79:1993;704-709.
77. Knudsen K., Beckman M., Blomberg S., Sjovall J., Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 78:1997;507-514.
78. Kobayashi Y., Ochiai R., Takeda J., Sekiguchi H., Fukushima K. Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. Anesth Analg. 74:1992;753-757.
79. Koblin D.D., Weiskopf R.B., Holmes M.A., Konopa K., Rampil I.J., Eger E.I. II, Waskell L. Metabolism of I-653 and isoflurane in swine. Anesth Analg. 68:1989;147-149.
80. Kopacz D.J., Emanuelsson B.M., Thompson G.E., Carpenter R.L., Stephenson C.A. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology. 81:1994;1139-1148.
81. Kurpiers E.M., Scharine J., Lovell S.L. Cost-effective anesthesia. desflurane versus propofol in outpatient surgery AANA J. 64:1996;69-75.
82. Kwek T.K., Ng A. Laryngeal mask insertion following inhalational induction in children. a comparison between halothane and sevoflurane Anaesth Intensive Care. 25:1997;413-416.
83. Larach D.R., Schuler H.G. Direct vasodilation by sevoflurane, isoflurane and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology. 75:1991;268-278.
84. Lee A., Fagan D., Lamont M., Tucker G.T., Halldin M., Scott D.B. Disposition kinetics of ropivacaine in humans. Anesth Analg. 69:1989;736-738.
85. Lee C., Tsai S.K., Kwan W.F., Chen B.J., Cheng M.L. Desflurane (I-653) potentiates atracurium in humans. a comparative study with isoflurane J Clin Anesth. 4:1992;448-454.
86. Lee C., Tsai S.K., Kwan W.F., Chen B.J., Cheng M. A clinical assessment of desflurane anaesthesia and comparison with isoflurane. Can J Anaesth. 40:1993;487-494.
87. Lerman J., David P.J., Welborn L.G., Orr R.J., Rabb M., Carpenter R., Motoyama E., Hannallah R., Haberkern C.M. Induction, recovery, and safety characteristics of sevoflurane in children underging ambulatory surgery. A comparison with halothane. Anesthesiology. 84:1996;1332-1340.
88. Lockhart S.H., Rampil I.J., Yasuda N., Eger E.I. II, Weiskopf R.B. Depression of ventilation by desflurane in humans. Anesthesiology. 74:1991;484-488.
89. Lutz L.J., Milde J.H., Milde L.N. The cerebral functional, metabolic and haemodynamic effects of desflurane in dogs. Anesthesiology. 73:1990;125-131.
90. Malan T., DiNardo J., Isner R.J., Frink E.J. Jr., Goldberg M., Fenster P.E., Brown E.A., Depa R., Hammond L.C., Mata H. Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. Anesthesiology. 83:1995;918-928.
91. Malviya S., Lerman J. The blood/gas solubility of sevoflurane, isoflurane, halothane and serum constituent concentrations in neonates and adults. Anesthesiology. 80:1990;814-824.
92. Markham A., Faulds D. Ropivacaine. a review of its pharmacology and therapeutic use in regional anaesthesia Drugs. 52:1996;429-449.
93. Martin J.L., Plevak D.J., Flannery K.D., Charlton M., Poterucha J.J., Humphreys C.E., Derfus G., Pohl L.R. Hepatotoxicity after desflurane anesthesia. Anesthesiology. 83:1995;1125-1129.
94. Mazze R.I., Woodruff R.E., Heerdt M.E. Isoniazid-induced enflurane defluorination in humans. Anesthesiology. 57:1982;5-8.
95. Mazzeo A.J., Cheng E.Y., Bosnjak Z.J., Coon R.L., Kampine J.P. Topographical differences in the direct effects of desflurane and halothane on canine airway smooth muscle. Anesth Analg. 78:1994;S274.
96. Merin R.G., Bernard J.M., Cohen M., Chelly J.E. Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiology. 74:1991;568-574.
97. Mitsuhata H., Saitoh J., Shimizu R., Takeuchi H., Hasome N., Horiguchi Y. Sevoflurane and isoflurane protect against bronchospasm in dogs. Anesthesiology. 81:1994;1230-1234.
98. Moore M.A., Weiskopf R.B., Eger E.I. II, Wilson C., Lu G. Arrythmogenic doses of epinephrine are similar during desflurane or sevoflurane anesthesia in humans. Anesthesiology. 79:1993;943-947.
99. Moore M.A., Weiskopf R.B., Eger E.I. II, Noorani M., McKay L., Damask M. Rapid 1% increases of end-tidal desflurane concentration to greater than 5% transiently increases heart rate and blood pressure in humans. Anesthesiology. 81:1994;94-98.
100. Morio M., Fujii K., Satoh N., Imai M., Kawakami U., Mizuno T., Kawai Y., Ogasawara Y., Tamura T., Negishi A. Reaction of sevoflurane and its degradation products with soda-lime. toxicity of the byproducts Anesthesiology. 77:1992;1155-1167.
101. Moriwaki G., Bito H., Ikeda K. Partly exhausted soda lime or soda lime with water added inhibits the increase in compound A concentration in the circle system during low flow sevoflurane anesthesia. Br J Anaesth. 79:1997;782-786.
102. Morrison L.M.M., Emanuelsson B.M., McClure J.H., Pollok A.J., McKeown D.W., Brockway M., Jozwiak H., Wildsmith J.A. Efficacy and kinetics of extradural ropivacaine. comparison with bupivacaine Br J Anaesth. 72:1994;164-169.
103. Morton C.P., Bloomfield S., Magnusson A., Jozwiak H., McClure J.H. Ropivacaine 0.75% for extradural anaesthesia in elective Caesarean section. an open clinical and pharmacokinetic study in mother and neonate Br J Anaesth. 79:1997;3-8.
104. Mostafa S.M., Atherton A.M.J. Sevoflurane for difficult tracheal intubation. Br J Anaesth. 79:1997;392-393.
105. Muir H.A., Writer D., Douglas J., Weeks S., Gambling D., Macarthur A. Double-blind comparison of epidural ropivacaine 0.25% and bupivacaine 0.25% for relief of childbirth pain. Can J Anaesth. 44:1997;599-604.
106. Muzzi D.A., Losasso T.J., Dietz N.M., Faust R.J., Milde L.N. The effects of desflurane on cerebrospinal fluid pressure in neurosurgical patients. Anesthesiology. 73:1990;A1215.
107. 2O on cerebrospinal fluid pressure in patients with supratentorial mass lesions. Anesthesiology. 75:1991;A167.
108. Naidu-Sjosvard K., Sjoberg F., Gupta A. Anaesthesia for videoarthroscopy of the knee. A comparison between desflurane and sevoflurane. Acta Anaesthesiol Scand. 42:1998;464-471.
109. Nakajima R., Nakajima Y., Ikeda K. Minimum alveolar concentrations of sevoflurane in elderly patients. Br J Anaesth. 70:1993;273-275.
110. Nancarrow C., Rutten A.J., Runciman W.B., Mather L.E., Carapetis R.J., McLean C.F., Hipkins S.F. Myocardial and cerebral drug concentrations and the mechanism of death after fatal intravenous doses of lidocaine, bupivacaine and ropivacaine in the sheep. Anesth Analg. 69:1989;276-283.
111. Navarro R., Weiskopf R., Moore M.A., Lockhart S., Eger E.I. II, Koblin D., Lu G., Wilson C. Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine. Anesthesiology. 80:1994;545-549.
112. Newberg L.A., Milde J.H., Michelfelder J.D. The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity. Anesthesiology. 59:1983;23-28.
113. Nishiyama T., Matsukawa T., Hanaoka K., Conway C.M. Interactions between nicardipine and enflurane, isoflurane and sevoflurane. Can J Anaesth. 44:1997;1071-1076.
114. Njoku D., Laster M.J., Gong D.H., Eger E.I. II, Reed G.F., Martin J.L. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins. association between protein acylation and hepatic injury Anesth Analg. 84:1997;173-178.
115. Oda Y., Furuichi K., Tanaka K., Hiroi T., Imaoka S., Asada A., Fujimori M., Funae Y. Metabolism of a new local anaesthetic, ropivacaine, by human hepatic cytochrome P450. Anesthesiology. 82:1995;214-220.
116. Ornstein E., Young W.L., Fleischer L.H., Ostapkovich N. Desflurane and isoflurane have similar effects on cerebral blood flow in patients with intracranial mass lesions. Anesthesiology. 79:1993;498-502.
117. Owen M.D., D'Angelo R., Gerancher J.C., Thompson J.M., Foss M.L., Babb J.D., Eisenach J.C. 0.125% ropivacaine is similar to 0.125% bupivacaine for labour analgesia using patient controlled epidural infusion. Anesth Analg. 86:1998;527-531.
118. Paris S.T., Cafferkey M., Tarling M., Hancock P., Yate P.M., Flynn P.J. Comparison of sevoflurane and halothane for outpatient dental anesthesia in children. Br J Anaesth. 79:1997;280-284.
119. Park K.W., Dai H.B., Lowenstein E., Sellke F.W. Epithelial dependence of the bronchodilatory effect of sevoflurane and desflurane in rat distal bronchi. Anesth Analg. 86:1998;646-651.
120. Park W.K., Pancrazio J.J., Suh C.K., Lynch C. Myocardial depressant effects of sevoflurane. Mechanical and electrophysiologic actions in vitro. Anesthesiology. 84:1996;1166-1176.
121. Parsons R.S., Jones R.M., Wrigley S.R., MacLeod K.G., Platt M.W. Comparison of desflurane and fentanyl based anaesthetic techniques for coronary artery bypass surgery. Br J Anaesth. 72:1994;430-438.
122. Patel S.S., Goa K.L. Sevoflurane. a review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia Drugs. 51:1996;658-700.
123. Philip B.K., Kallar S.K., Bogetz M.S., Scheller M.S., Wetchler B.V. A multicenter comparison of maintenance and recovery with sevoflurane or isoflurane for adult ambulatory anesthesia. The Sevoflurane Multicenter Ambulatory Group. Anesth Analg. 83:1996;314-319.
124. Pitkanen M., Covino B.G., Feldman H.S., Arthur G.R. Chronotropic and inotropic effects of ropivacaine, bupivacaine and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart. Reg Anesth. 17:1992;183-192.
125. Priebe H.J. Isoflurane causes more regional myocardial dysfunction than halothane in dogs with a critical coronary artery stenosis. Anesthesiology. 69:1988;72-83.
126. Rampil I.J., Weiskopf R.B., Brown J.G., Eger E.I. II, Johnson B.H., Holmes M.A., Donegan J.H. I-653 and isoflurane produce similar dose related changes in the electroencephalogram of pigs. Anesthesiology. 69:1988;295-302.
127. Rampil I.J., Zwass M., Lockhart S.H., Eger E.I. II, Johnson B.H., Yasuda N., Weiskopf R.B. Hemodynamics of I-653 in patients. Anesthesiology. 71:1989;A25.
128. Rampil I.J., Lockhart S.H., Eger E.I. II, Yasuda N., Weiskopf R.B., Cahalan M.K. The electroencephalographic effects of desflurane in humans. Anesthesiology. 74:1991;434-439. a.
129. Rampil I.J., Lockhart S.H., Zwass M.S., Peterson N., Yasuda N., Eger E.I. II, Weiskopf R.B., Damask M.C. Clinical characteristics of desflurane in surgical patients. minimum alveolar concentration Anesthesiology. 74:1991;429-433. b.
130. Rapp S.E., Conahan T.J., Pavlin D.J., Levy W.J., Hautman B., Lecky J., Luke J., Nessly M.L. Comparison of desflurane with propofol in outpatients undergoing peripheral orthopedic surgery. Anesth Analg. 75:1992;572-579.
131. Ray D.C., Drummond G.B. Halothane hepatitis. Br J Anaesth. 67:1991;84-99.
132. Saitoh Y., Toyooka H., Amaha K. Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anesthetics and neuroleptanesthesia. Br J Anaesth. 70:1993;402-404.
133. Scheller M.S., Nakakimura K., Fleischer J.E., Zornow M.H. Cerebral effects of sevoflurane in the dog. comparison with isoflurane and enflurane Br J Anaesth. 65:1990;388-392.
134. Scott D.B., Lee A., Fagan D., Bowler G.M.R., Bloomfield P., Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 69:1989;563-569.
135. Searle N.R., Martineau R.J., Conzen P., al-Hasani A., Mark L., Ebert T., Muzi M., Hodgins L.R. Comparison of sevoflurane/fentanyl and isoflurane/fentanyl during elective coronary artery bypass surgery. Can J Anaesth. 43:1996;890-899.
136. Sebel P.S., Glass P.S.A., Fletcher J.E., Murphy M.R., Gallagher C., Quill T. Reduction of the MAC of desflurane with fentanyl. Anesthesiology. 76:1992;52-59.
137. Shimizu T., Abe K., Kinouchi K., Yoshiya I. Arterial oxygenation during one lung ventilation. Can J Anaesth. 44:1997;1162-1166.
138. Sigston P.E., Jenkins A.M., Jackson E.A., Sury M.R., Mackersie A.M., Hatch D.J. Rapid inhalation induction in children. 8% sevoflurane compared with 5% halothane Br J Anaesth. 78:1997;362-365.
139. Smiley R.M., Ornstein E., Pantuck E.J., Pantuck C.B., Matteo R.S. Metabolism of desflurane and isoflurane to fluoride ion in surgical patients. Can J Anaesth. 38:1991;965-968.
140. Song D., Joshi G.P., White P.F. Fast track eligibility after ambulatory anesthesia. a comparison of desflurane, sevoflurane and propofol Anesth Analg. 86:1998;267-273.
141. Stienstra R., Jonker T.A., Bourdrez P., Kuijpers J.C., VanKleef J.W., Lundberg U. Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labour. a double blind comparison Anesth Analg. 80:1995;285-289.
142. Strebel S., Lam A.M., Matta B., Mayberg T.S., Aaslid R., Newell D.W. Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthsia. Anesthesiology. 83:1995;66-76.
143. Strum D.P., Eger E.I. II Partition coefficients for sevoflurane in human blood, saline and olive oil. Anesth Analg. 66:1987;654-656.
144. Sutton T.S., Koblin D.D., Gruenke L.D., Weiskopf R.B., Rampil I.J., Waskell L., Eger E.I. II Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth Analg. 73:1991;180-185.
145. Taguchi M., Watanabe S., Asakura N., Inomata S. End-tidal sevoflurane concentrations for laryngeal mask airway insertion and for tracheal intubation in children. Anesthesiology. 81:1994;628-631.
146. Talke P., Caldwell J., Dodsont B., Richardson C.A. Desflurane and isoflurane increase lumbar cerebrospinal fluid pressure in normocapnic patients undergoing transphenoidal hypophysectomy. Anesthesiology. 85:1996;999-1004.
147. Taylor R.H., Lerman J. Minimum alveolar concentration of desflurane and hemodynamic responses in neonates, infants and children. Anesthesiology. 75:1991;975-979.
148. Terasako K., Ishii S. Postoperative seizure-like activity following sevoflurane anesthesia. Acta Anaesthesiol Scand. 40:1996;953-954.
149. Thomson I.R., Bowering J.B., Hudson R.J., Frais M.A., Rosenbloom M. A comparison of desflurane and isoflurane in patients undergoing coronary artery surgery. Anesthesiology. 75:1991;776-781.
150. Thwaites A., Edmends S., Smith I. Inhalational induction with sevoflurane. a double-blind comparison with propofol Br J Anaesth. 78:1997;356-361.
151. Tryba M., Zenz M., Thole H., Pern U. Ropivacaine 0.5% vs ropivacaine 0.25% for axillary brachial plexus anesthesia - a double blind study. Anesthesiology. 77:1992;A891.
152. Tsai S.K., Lee C., Kwan W.F., Chen B.J. Recovery of cognitive functions after anaesthesia with desflurane or isoflurane and nitrous oxide. Br J Anaesth. 69:1992;255-258.
153. van Kleef J.W., Veering B.T., Burm A.G.L. Spinal anesthesia with ropivacaine. a double-blind study on the efficacy and safety of 0.5% and 0.75% solutions in patients undergoing minor lower limb surgery Anesth Analg. 78:1994;1125-1130.
154. Wallin R.F., Regan B.M., Napoli M., Stern I.J. Sevoflurane. a new inhalational agent Anesth Analg. 54:1975;758-766.
155. Weiskopf R.B., Holmes M.A., Rampil I.J., Johnson B.H., Yasuda N., Targ A.G., Eger E.I. II Cardiovascular safety and actions of high concentrations of I-653 and isoflurane in swine. Anesthesiology. 70:1989;793-798.
156. Weiskopf R.B., Cahalan M.K., Eger E.I. II, Yasuda N., Rampil I.J., Ionescu P., Lockhart S.H., Johnson B.H., Freire B., Kelley S. Cardiovascular actions of desflurane in normocarbic volunteers. Anesth Analg. 73:1991;143-156. a.
157. Weiskopf R.B., Cahalan M.K., Ionescu P., Eger E.I. II, Yasuda N., Lockhart S.H., Rampil I.J., Laster M., Freire B., Peterson N. Cardiovascular actions of desflurane with and without nitrous oxide during spontaneous ventilation in humans. Anesth Analg. 73:1991;165-174. b.
158. Welborn L.G., Hannallah R.S., Norden J.M., Ruttimann U.E., Callan C.M. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg. 83:1996;917-920.
159. Wolff A.P., Hasselstrom L., Kerkkamp H.E., Gielen M.J. Extradural ropivacaine and bupivacaine in hip surgery. Br J Anaesth. 74:1995;458-460.
160. Woodforth I.J., Hicks R.G., Crawford M.R., Stephen J.P., Burke D.J. Electroencephalographic evidence of seizure activity under deep sevoflurane anesthesia in a non epileptic patient. Anesthesiology. 87:1997;1579-1582.
161. Yasuda N., Lockhardt S.H., Eger E.I. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg. 72:1991;316-324. a.
162. Yasuda N., Lockhart S.H., Eger E.I. II, Weiskopf R.B., Johnson B.H., Freire B.A., Fassoulaki A. Kinetics of desflurane, isoflurane and halothane in humans. Anesthesiology. 74:1991;489-498. b.
163. Zaric D., Axelsson K., Nydhal P.A., Philipsson L., Larsson P., Jansson J.R. Sensory and motor blockade during epidural analgesia with 1%, 0.75%, and 0.5% ropivacaine. a double blind study Anesth Analg. 72:1991;509-515.
164. Zwass M.S., Fisher D.M., Welborn L.G., Cote C.J., Davis P.J., Dinner M., Hannallah R.S., Letty M.P., Liu M.D., Sarner J., McGill W.A., Alifimoff J.K., Embree P.D., Book D.R. Induction and maintenance characteristics of anesthesia with desflurane and nitrous oxide in infants and children. Anesthesiology. 76:1992;373-378.